Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helong Xiao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cardiovascular Drugs and Therapy|May 4, 2026
NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway ActivationTing Wang, Helong Xiao, Meijian Yang, et al.
Neurourology and Urodynamics|February 15, 2024
The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitisHelong Xiao, Ting Wang, Bo Gao, et al.
Digital Health|January 26, 2026
A cross-sectional study of the quality and reliability of renal cell carcinoma-related short videos on Bilibili and TikTokJianzhi Su, Helong Xiao, Qinghui Xiao, et al.
Drug Development Research|October 28, 2020
Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathwayJunjiang Liu, Yunxia Zhang, Chunhong Yu, et al.
Translational Andrology and Urology|October 22, 2024
NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cellsShoubin Li, Chunhong Yu, Helong Xiao, et al.
Frontiers in Oncology|April 17, 2023
Malignant glomus tumor of prostate: A case reportZhanxin Sun, Fuzhen Sun, Chunhong Yu, et al.
Urology Journal|October 1, 2020
Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder CancerShoubin Li, Yi Jia, Chunhong Yu, et al.
Oncology Letters|March 15, 2019
Induction of entosis in prostate cancer cells by nintedanib and its therapeutic implicationsJunjiang Liu, Lei Wang, Yunxia Zhang, et al.
Biomed Research International|September 9, 2020
Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate CancerShoubin Li, Chunhong Yu, Yunxia Zhang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cardiovascular Drugs and Therapy|May 4, 2026
NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway ActivationTing Wang, Helong Xiao, Meijian Yang, et al.
Neurourology and Urodynamics|February 15, 2024
The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitisHelong Xiao, Ting Wang, Bo Gao, et al.
Digital Health|January 26, 2026
A cross-sectional study of the quality and reliability of renal cell carcinoma-related short videos on Bilibili and TikTokJianzhi Su, Helong Xiao, Qinghui Xiao, et al.
Drug Development Research|October 28, 2020
Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathwayJunjiang Liu, Yunxia Zhang, Chunhong Yu, et al.
Translational Andrology and Urology|October 22, 2024
NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cellsShoubin Li, Chunhong Yu, Helong Xiao, et al.
Frontiers in Oncology|April 17, 2023
Malignant glomus tumor of prostate: A case reportZhanxin Sun, Fuzhen Sun, Chunhong Yu, et al.
Urology Journal|October 1, 2020
Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder CancerShoubin Li, Yi Jia, Chunhong Yu, et al.
Oncology Letters|March 15, 2019
Induction of entosis in prostate cancer cells by nintedanib and its therapeutic implicationsJunjiang Liu, Lei Wang, Yunxia Zhang, et al.
Biomed Research International|September 9, 2020
Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate CancerShoubin Li, Chunhong Yu, Yunxia Zhang, et al.
Pageof 1